These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 16837065)
1. CD28-CD57+ T cells predominate in CD8 responses to glatiramer acetate. Ratts RB; Lovett-Racke AE; Choy J; Northrop SC; Hussain RZ; Karandikar NJ; Racke MK J Neuroimmunol; 2006 Sep; 178(1-2):117-29. PubMed ID: 16837065 [TBL] [Abstract][Full Text] [Related]
2. Pars planitis is associated with an increased frequency of effector-memory CD57+ T cells. Pedroza-Seres M; Linares M; Voorduin S; Enrique RR; Lascurain R; Garfias Y; Jimenez-Martinez MC Br J Ophthalmol; 2007 Oct; 91(10):1393-8. PubMed ID: 17475702 [TBL] [Abstract][Full Text] [Related]
6. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy. Stone SF; Price P; French MA HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533 [TBL] [Abstract][Full Text] [Related]
7. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus-specific human CD8(+) T cells. Merino J; Ramírez N; Moreno C; Toledo E; Fernández M; Sánchez-Ibarrola A Clin Exp Immunol; 2007 Jul; 149(1):87-96. PubMed ID: 17425655 [TBL] [Abstract][Full Text] [Related]
8. Phenotypic characterization of autoreactive T cells in multiple sclerosis. Ratts RB; Karandikar NJ; Hussain RZ; Choy J; Northrop SC; Lovett-Racke AE; Racke MK J Neuroimmunol; 2006 Sep; 178(1-2):100-10. PubMed ID: 16901549 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a cytotoxic CD57+ T cell subset from patients with pulmonary tuberculosis. Sada-Ovalle I; Torre-Bouscoulet L; Valdez-Vázquez R; Martínez-Cairo S; Zenteno E; Lascurain R Clin Immunol; 2006 Dec; 121(3):314-23. PubMed ID: 17035093 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of naive Th1 CD4+ T cells by glatiramer acetate in multiple sclerosis. Kantengwa S; Weber MS; Juillard C; Benkhoucha M; Fellay B; Zamvil SS; Gougeon ML; Chofflon M; Lalive PH J Neuroimmunol; 2007 Apr; 185(1-2):123-9. PubMed ID: 17306890 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory process of CD8+ CD28- T cells in induced sputum from asthmatic patients. Hamzaoui A; Chaouch N; Graïri H; Ammar J; Hamzaoui K Mediators Inflamm; 2005 Aug; 2005(3):160-6. PubMed ID: 16106102 [TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis of CD4+ T cells by immunomodulatory therapy of multiple sclerosis with glatiramer acetate. Rieks M; Hoffmann V; Aktas O; Juschka M; Spitzer I; Brune N; Schimrigk S; Przuntek H; Pöhlau D Eur Neurol; 2003; 50(4):200-6. PubMed ID: 14634263 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of TRAIL expression on human T lymphocytes by interferon beta and glatiramer acetate. Arbour N; Rastikerdar E; McCrea E; Lapierre Y; Dörr J; Bar-Or A; Antel JP Mult Scler; 2005 Dec; 11(6):652-7. PubMed ID: 16320724 [TBL] [Abstract][Full Text] [Related]
14. Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs: an observational case-control study. Onyema OO; Decoster L; Njemini R; Forti LN; Bautmans I; De Waele M; Mets T BMC Cancer; 2015 Dec; 15():1016. PubMed ID: 26711627 [TBL] [Abstract][Full Text] [Related]
15. Expansions of CD4+CD28- and CD8+CD28- T cells in granulomatosis with polyangiitis and microscopic polyangiitis are associated with cytomegalovirus infection but not with disease activity. Eriksson P; Sandell C; Backteman K; Ernerudh J J Rheumatol; 2012 Sep; 39(9):1840-3. PubMed ID: 22753656 [TBL] [Abstract][Full Text] [Related]
16. Long-term therapy with glatiramer acetate in multiple sclerosis: effect on T-cells. Ragheb S; Abramczyk S; Lisak D; Lisak R Mult Scler; 2001 Feb; 7(1):43-7. PubMed ID: 11321193 [TBL] [Abstract][Full Text] [Related]
17. Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL). Porakishvili N; Roschupkina T; Kalber T; Jewell AP; Patterson K; Yong K; Lydyard PM Clin Exp Immunol; 2001 Oct; 126(1):29-36. PubMed ID: 11678896 [TBL] [Abstract][Full Text] [Related]
18. Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis. Putheti P; Soderstrom M; Link H; Huang YM J Neuroimmunol; 2003 Nov; 144(1-2):125-31. PubMed ID: 14597106 [TBL] [Abstract][Full Text] [Related]
19. Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing-remitting multiple sclerosis patients. Berthelot L; Miqueu P; Pettré S; Guillet M; Moynard J; Wiertlewski S; Lefrère F; Brouard S; Soulillou JP; Laplaud DA Clin Immunol; 2010 Apr; 135(1):33-42. PubMed ID: 20116333 [TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis. Hooper M; Kallas EG; Coffin D; Campbell D; Evans TG; Looney RJ J Rheumatol; 1999 Jul; 26(7):1452-7. PubMed ID: 10405929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]